Suddenly, cannabis-related, hemp-derived CBD is almost everywhere. CBD’s FDA status is murky, and we know very little about its benefits, thanks in part to its former place on DEA Schedule 1. How much has been proven about its supposed health qualities? What are the risks? Experts discuss in depth.

Guests:

  • Joanne, Florida RN and CBD user
  • Dr. Yasmin Hurd, Director, Addiction Institute, Icahn School of Medicine at Mount Sinai, New York
  • Don Ballou, founder and CEO, CBD Essence Products
  • Dr. Tim Welty, Director, Research, Innovation and International Programs, College of Pharmacy and Health Sciences, Drake University

Links for more information:

Stay in the loop! Follow us on Twitter and Instagram and like us on FacebookSubscribe, rate and review on Apple Podcasts.

Posted by:Producer

MTC is the producer of Viewpoints and Radio Health Journal - celebrating 25 years of award-winning public affairs radio reaching 6 million listeners each week.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.